VeriMomsh-tetrapeptide-38 trifluoroacetate hamilelikte güvenli mi?
No harmonised CLP reproductive classification located (ECHA Annex VI). No SCCS or CIR safety assessment or peer‑reviewed reproductive/toxicology studies identified for 'sh-tetrapeptide-38 trifluoroacetate' or tetrapeptide-38 indicating reproductive hazard. Peptides of this size are generally polar and have low dermal/systemic absorption in the absence of penetration enhancers, supporting negligible exposure from topical cosmetic use (sources searched: ECHA Annex VI, SCCS/CIR databases, PubMed, ECHA registration/CosIng, PubChem, EWG).
Related ingredients
Frequently asked questions
- sh-tetrapeptide-38 trifluoroacetate hamilelikte güvenli mi?
- No harmonised CLP reproductive classification located (ECHA Annex VI). No SCCS or CIR safety assessment or peer‑reviewed reproductive/toxicology studies identified for 'sh-tetrapeptide-38 trifluoroacetate' or tetrapeptide-38 indicating reproductive hazard. Peptides of this size are generally polar and have low dermal/systemic absorption in the absence of penetration enhancers, supporting negligible exposure from topical cosmetic use (sources searched: ECHA Annex VI, SCCS/CIR databases, PubMed, ECHA registration/CosIng, PubChem, EWG).
- sh-tetrapeptide-38 trifluoroacetate emzirirken güvenli mi?
- No data found indicating systemic exposure, transfer into breastmilk, or lactation toxicity. Given the lack of reproductive or developmental hazard data and expected low dermal absorption of short peptides, exposure via breastmilk is considered negligible for topical cosmetic use (sources searched: SCCS/CIR, PubMed, PubChem, CosIng, ECHA).
- sh-tetrapeptide-38 trifluoroacetate bebek cildi için güvenli mi?
- No infant‑specific reproductive or toxicity data found. Mechanistic/toxic effects not identified. Exposure rating increased by +1 for baby skin relative to adults because infants have an immature skin barrier and higher surface‑area‑to‑weight ratio; although adult dermal absorption is considered negligible, infant exposure is plausibly low but measurable for topical application. No evidence found of specific hazard to infants aged 0–3 years (sources searched: PubMed, CosIng, ECHA, PubChem, EWG).
- VeriMom sh-tetrapeptide-38 trifluoroacetate nasıl puanlıyor?
- VeriMom sh-tetrapeptide-38 trifluoroacetate'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte sh-tetrapeptide-38 trifluoroacetate yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.